In the year 2006, we enhanced our existing portfolio by acquiring a range of products from PD Pharmaceuticals as well as in–licensing a range of dermatological products from MZ Pharmaceuticals. These additions helped us immensely and contributed towards our strong presence in the dermatology segment of the region.

The Kenya subsidiary is the largest subsidiary for us in the Africa region with Glenmark being ranked among the top 3 companies in the country.